{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-oral/management/oral-candida-infection/","result":{"pageContext":{"chapter":{"id":"dcda2b7f-7a28-5b54-81d7-74ca0a1293ac","slug":"oral-candida-infection","fullItemName":"Scenario: Oral candida infection","depth":2,"htmlHeader":"<!-- begin field a47b104c-551b-4787-9941-f27ce6be20be --><h2>Scenario: Oral candida infection</h2><!-- end field a47b104c-551b-4787-9941-f27ce6be20be -->","summary":"Covers the management of patients with Candida infection of the mouth (oral thrush).","htmlStringContent":"<!-- begin item c43412c2-7409-4ce3-bc17-a3808e01225b --><!-- begin field 29b187a1-9478-41d3-8e5f-acbc015b3127 --><p>From age 16 years onwards.</p><!-- end field 29b187a1-9478-41d3-8e5f-acbc015b3127 --><!-- end item c43412c2-7409-4ce3-bc17-a3808e01225b -->","topic":{"id":"ba62b1ab-ffea-5bce-8fd6-6127df66395a","topicId":"dc5a4c25-cbc0-4da8-9263-892c0ddb29be","topicName":"Palliative care - oral","slug":"palliative-care-oral","lastRevised":"Last revised in October 2018","chapters":[{"id":"92b78ff5-a7a3-533b-9fad-3812221a3e70","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e63cc0ed-d679-5b57-bd5d-a0fffc2bb1c5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0d446cc8-8026-59f2-8be3-a3df05f54690","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"94667ccb-b451-5743-aeb8-44fbce6caf13","slug":"changes","fullItemName":"Changes"},{"id":"d267c387-0c44-5636-b186-efd35314ddb7","slug":"update","fullItemName":"Update"}]},{"id":"b1959eca-8652-570a-bf43-e03f35359c72","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"190545c6-de91-566d-97ca-ec507ec5ffd5","slug":"goals","fullItemName":"Goals"},{"id":"51115a15-fe56-57ee-99b3-cdd5c4f1c6a0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4d5ef3b4-1232-5943-8fad-b29aa5998488","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"80c55ca1-b9c4-5b9f-9bc7-c6c5fd42df42","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"909bc973-bd01-5f89-8719-11278e3eec78","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6f3efef7-3ed5-5013-9a70-606c9dbe0943","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"78d7fe5a-a1b6-58ed-9302-ad88f95d8db5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f6c72ae5-a1db-5d81-b680-40d5e677f0e7","slug":"causes","fullItemName":"Causes"},{"id":"c6626f56-2d11-59eb-aaa1-7df1a7759a57","slug":"oral-problems","fullItemName":"Oral problems"},{"id":"047eef6e-58db-5c3e-bbc9-a5b23171e78a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"efa65b1a-1a58-5453-b232-dcb7a4ad4533","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"87dda915-3779-5f4a-afd9-f77577bf772b","slug":"complications","fullItemName":"Complications"}]},{"id":"8d836099-7e31-5881-bb05-20f08d446d0b","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b391498b-1e1b-5dcb-a663-5c2acc77475b","slug":"history","fullItemName":"History"},{"id":"b7bc660c-5027-59c4-b81e-daabd0aae4ef","slug":"examination","fullItemName":"Examination"},{"id":"01753f6e-7f5f-5eea-a4f5-860d02375047","slug":"investigations","fullItemName":"Investigations"}]},{"id":"b7921f28-c4d4-513c-9424-c072661841bd","fullItemName":"Management","slug":"management","subChapters":[{"id":"8e4de9d8-84d5-5ccb-a53b-b45928ebc3e0","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"b1f750e8-79b4-5942-abd9-85bc539f3606","slug":"prevention","fullItemName":"Scenario: Prevention"},{"id":"1fcf7fd1-2915-57d3-b741-40d617974983","slug":"dry-mouth","fullItemName":"Scenario: Dry mouth"},{"id":"89366510-b0a8-56fc-bf18-765bf712040e","slug":"oral-pain","fullItemName":"Scenario: Oral pain"},{"id":"dcda2b7f-7a28-5b54-81d7-74ca0a1293ac","slug":"oral-candida-infection","fullItemName":"Scenario: Oral candida infection"},{"id":"ceee9eeb-7174-5047-ae7d-904f58b5e2df","slug":"mouth-ulcers-mucositis","fullItemName":"Scenario: Mouth ulcers and mucositis"},{"id":"ceebbe2f-4f2d-5b69-8484-69a7b63d4155","slug":"halitosis-excessive-salivation-altered-taste","fullItemName":"Scenario: Halitosis, excessive salivation and altered taste"},{"id":"ae4a6023-826b-5bf3-8610-183b69c705c0","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"f953784c-8686-5a90-92cd-60d68dbd6845","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"26f08b6c-5b56-5782-8732-efb4b6e713af","slug":"topical-artificial-saliva-saliva-stimulant-products","fullItemName":"Topical artificial saliva and saliva stimulant products"},{"id":"96912fd4-a2b4-50f9-86ed-8bb2e45463c5","slug":"oral-pilocarpine","fullItemName":"Oral pilocarpine"},{"id":"c8127148-af88-5ea4-860a-50fcf5aac054","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"fff90e93-10dd-553e-82f8-0dfd41609a37","slug":"oral-antifungals","fullItemName":"Oral antifungals"},{"id":"065c7442-bd39-51f9-a981-cdaccb1ba40c","slug":"chlorhexidine","fullItemName":"Chlorhexidine"},{"id":"94720495-b83a-5896-aad4-6fe5a74a5f78","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"1c9aa8fa-0094-5e8d-9745-40f1deb0a4bd","slug":"antivirals","fullItemName":"Antivirals"},{"id":"ccf55d3d-9d86-5178-b7de-efe3554f8ad1","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"e8b50dff-617d-541c-8f6c-32d1cc172ad5","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"49c2337d-75af-5e94-a422-dce3f68c22c5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"87ab81b8-3331-56e9-97da-8ccde09bb168","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fcdbc4c2-0265-55de-83ef-890d4a2eb6e8","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2d5e11b2-f829-5c8a-ba4e-4bd0c552209e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4a6cc052-004c-5f0c-83f8-f04899c06292","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e1ee9217-75fd-57a2-8e67-0f9c468e36c9","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a6d40f6b-b733-5a56-8b81-ff55062d9bcb","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b7921f28-c4d4-513c-9424-c072661841bd","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1c0de358-d639-541e-9009-ec6246534e4d","slug":"oral-candida-infection","fullItemName":"Oral candida infection","depth":3,"htmlHeader":"<!-- begin field a693592d-27c4-4c42-ae2d-7582668a9339 --><h3>Oral candida infection</h3><!-- end field a693592d-27c4-4c42-ae2d-7582668a9339 -->","summary":null,"htmlStringContent":"<!-- begin item 5ac9037b-8d42-4ad6-b303-0fbd22212baf --><!-- begin field e0da8c2e-ceae-4d0b-92cf-89713c0052a9 --><ul><li>Manage predisposing local and systemic <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/background-information/risk-factors/\">risk factors</a> for oral candida infection in conjunction with anticandidal treatment.</li><li><strong>In immunocompetent people:</strong><ul><li>Topical nystatin, or miconazole is recommended as first-line treatment.</li><li>Oral fluconazole is recommended for persistent candidiasis that does not respond to topical treatment.</li></ul></li><li><strong>In immunocompromised people, </strong>high-dose oral fluconazole is generally preferred for first-line treatment.</li><li>Chlorhexidine should be used to clean dentures, and may be used as an adjunct to topical or oral treatment.</li><li>For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/oral-candida-infection/#anticandidal-drug-treatment\">Anticandidal drug treatment</a>.</li><li><strong>If oral candidiasis persists, seek specialist advice.</strong></li></ul><!-- end field e0da8c2e-ceae-4d0b-92cf-89713c0052a9 --><!-- end item 5ac9037b-8d42-4ad6-b303-0fbd22212baf -->","subChapters":[{"id":"603346ec-9b90-53c6-b03b-5c87c12052b9","slug":"anticandidal-drug-treatment","fullItemName":"Anticandidal drug treatment","depth":4,"htmlHeader":"<!-- begin field bd232653-8d5e-4269-8a23-5b5cb46b6cad --><h4>Anticandidal drug treatment</h4><!-- end field bd232653-8d5e-4269-8a23-5b5cb46b6cad -->","summary":null,"htmlStringContent":"<!-- begin item c8cbd793-0105-44e3-a868-e2a80ba675ad --><!-- begin field 855a455b-7b35-4eb2-863a-14197bc71189 --><ul><li>The choice of anticandidal drug treatment may be dictated by local policy or based on advice from a local microbiologist.</li><li>People should be advised to keep the drug formulation in contact with the oral mucosal surface for as long as possible by:<ul><li>Holding the formulation in the mouth for as long as possible before swallowing.</li><li>Avoiding eating or drinking for 30 minutes after each dose [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Regnard, 2010</a>].</li><li>When using topical preparations, removing dentures before each administration and cleaning before re-insertion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Twycross et al, 2009</a>].</li></ul></li><li>Oral antifungals are reserved for widespread (for example evidence of oesophageal candidiasis) or severe infection, or when topical anticandidals are not tolerated or are ineffective:<ul><li>Oral ketoconazole — the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has suspended the marketing authorisation for oral ketoconazole, and it should not be prescribed for the treatment of fungal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">MHRA, 2013b</a>]. The decision was made because some people taking these medicines may be at an increased risk of liver damage and the risk outweighs the benefits. Alternative antifungal treatments are available.</li><li>Itraconazole is an alternative, but it is less suitable for people at high risk of heart failure. Reports of heart failure have been rare, but the risk seems to be higher in elderly people, people with cardiac disease, people taking negative inotropic drugs (for example calcium-channel blockers), and people taking high doses or receiving longer treatment courses [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">BNF 72, 2016</a>].</li><li>Dentures should be removed at least once a day and the underside cleaned to remove any adherent infected debris [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Twycross et al, 2009</a>]. For maximum patient comfort, dentures should be rinsed under running water after every meal and the lining of the mouth should be checked for food debris, and dentures left out overnight [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies and Finlay, 2005</a>].</li></ul></li><li>Nystatin and chlorhexidine mouthwash should not be used at the same time, as they will inactivate each other [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Regnard, 2010</a>]. They should be used 1 hour apart.</li><li>Thirty minutes must also be left between the use of toothpaste and chlorhexidine mouthwash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Kinley, Personal Communication, 2007</a>].</li></ul><!-- end field 855a455b-7b35-4eb2-863a-14197bc71189 --><!-- end item c8cbd793-0105-44e3-a868-e2a80ba675ad -->","subChapters":[]},{"id":"14e45c43-cae5-55f3-9038-99f13f0648e8","slug":"basis-for-recommendation-931","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9ca2d00d-eaa0-4258-ab14-0dee1dbc776d --><h4>Basis for recommendation</h4><!-- end field 9ca2d00d-eaa0-4258-ab14-0dee1dbc776d -->","summary":null,"htmlStringContent":"<!-- begin item 93128539-7a3f-464d-a262-38694f30ba5f --><!-- begin field 8f434f2a-55c8-4b64-b70c-b90bc3221ba2 --><p>These recommendations represent the general consensus from palliative care resources and local guidelines written by experts on the basis of experience of clinical practice [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies and Finlay, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">WeMeReC, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Regnard, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Twycross, 2014</a>].</p><ul><li>From an evidence-based perspective:<ul><li>Few trials have compared the use of topical anticandidal treatments in people with cancer in palliative care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Pankhurst, 2012</a>].</li><li>A Cochrane review investigated treatment of oral candidiasis in people with cancer receiving treatment and found that evidence about the clinical effects of oral antifungals was insufficient to make strong recommendations for patient care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Worthington et al, 2010</a>].</li></ul></li><li>Resistance to nystatin is uncommon although resistance to miconazole is becoming increasingly common, especially in people who are immunocompromised [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies and Finlay, 2005</a>].</li><li><strong>Mouthwashes </strong>are licensed for treatment of oral candidiasis:<ul><li>However, apart from their use in disinfecting dentures, evidence is insufficient to recommend their sole use for treating oral candidiasis.</li><li>The adjunctive use of chlorhexidine in oral candidiasis produces varying degree of success [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Ellepola and Samaranayake, 2001</a>]. The available evidence about the clinical effects of oral antifungals is insufficient to make strong recommendations for patient care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Worthington et al, 2010</a>].</li></ul></li></ul><!-- end field 8f434f2a-55c8-4b64-b70c-b90bc3221ba2 --><!-- end item 93128539-7a3f-464d-a262-38694f30ba5f -->","subChapters":[]}]},{"id":"c7b99281-7a71-54dc-a0b8-39e98effc82b","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 3d4285d0-8120-4770-ad5d-7b31cb981ba3 --><h3>Referral</h3><!-- end field 3d4285d0-8120-4770-ad5d-7b31cb981ba3 -->","summary":null,"htmlStringContent":"<!-- begin item ac84bae4-ad53-478e-b4a2-427858ea5865 --><!-- begin field 1c83020f-d8ce-44b1-9cd2-7c78774f499b --><ul><li><strong>Refer or seek specialist advice if in doubt about the diagnosis or management of any oral problem.</strong></li><li><strong>Refer if any of the following are present:</strong><ul><li>Oral problems that are causing a decrease in oral intake or concerns about nutrition.</li><li>Severe oral herpes simplex infection. Intravenous administration of aciclovir may be needed if pain limits the person's ability to take oral medication.</li><li>Severe mucositis. It can be extremely painful and may limit the person's ability to tolerate chemotherapy or radiotherapy.</li><li>Suspected neutropenic ulcers and neutropenia. Urgent medical advice should be sought because recovery of the neutrophil count is needed for healing.</li><li>Severe or persistent candida infection.</li><li>Oral ulcers that are bleeding.</li><li>Taste disturbance that is likely to be prolonged. Refer to a dietitian where appropriate.</li><li>Pain that is difficult to manage.</li><li>Communication problems. Refer to a speech and language therapist where appropriate.</li></ul></li></ul><!-- end field 1c83020f-d8ce-44b1-9cd2-7c78774f499b --><!-- end item ac84bae4-ad53-478e-b4a2-427858ea5865 -->","subChapters":[{"id":"bf7120f0-e3f0-5ea9-a583-f7c0817c584a","slug":"basis-for-recommendation-068","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1df8966a-f63d-4c55-b17b-c750a182bfe4 --><h4>Basis for recommendation</h4><!-- end field 1df8966a-f63d-4c55-b17b-c750a182bfe4 -->","summary":null,"htmlStringContent":"<!-- begin item 06845d82-288b-46d9-88d5-208141427381 --><!-- begin field be07dced-6e8e-4ca3-b1aa-851efdbc6330 --><p>These recommendations are based on standard clinical practice.</p><!-- end field be07dced-6e8e-4ca3-b1aa-851efdbc6330 --><!-- end item 06845d82-288b-46d9-88d5-208141427381 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}